Current strategies to prevent stroke in atrial fibrillation may require a closer look, according to two new studies.

Postmarket surveillance data revealed that enfortumab vedotin (EV) skin toxicity is associated with high hospitalization and ...

A lottery with cash prizes got people to take their antihypertensive medications, but improved adherence didn’t translate to better blood pressure.

Weight loss at the time of GLP-1 discontinuation was 10.1% overall, 9.7% for those with T2D, and 11.1% for those without.

These studies represent promising new treatment options for chronic and progressive kidney diseases, offering renewed hope to ...

Two phase 3 trials will study Kura Oncology’s ziftomenib for frontline acute myeloid leukemia, one with venetoclax and the ...

Michelle O’Donoghue and Gregory Marcus review the clinical implications of the DECAF randomized trial of caffeinated coffee or avoiding caffeine after successful cardioversion for atrial fibrillation.

Covert operations, online takedowns, and multimillion-pound seizures – how regulators are tackling the criminal networks ...

Researchers assess ultraprocessed food intake and the incidence of early-onset colorectal cancer precursors in a cohort of nearly 30,000 women.

A new opinion paper shows no convincing evidence that there is a causal link between gut bacteria and autism, citing weak ...

Dr Mark Kris discusses how a small 2015 study with just two nivolumab doses led to a wave of curative-intent trials.

Ethicist Art Caplan discusses FDA layoffs and their impact on protection of human research subjects in clinical trials.